ASPEN PHARMACARE HOLDINGS LIMITED |
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 219,2 ZAR | -2,16 % |
|
-0,50 % | +7,71 % |
| 08.03. | Aspen Pharmacare Holdings Limited kündigt Änderungen im Vorstand an | CI |
| 05.03. | Aspen Pharmacare Holdings Limited sucht Akquisitionen | CI |
Kurzporträt
- Pharmazeutika (71,6%): Anästhesieprodukte, Thromboseprodukte, zytotoxische Produkte usw.;
- Sonstige (28,4%): Produkte für die Säuglingsernährung und Verbraucherprodukte.
Ende Juni 2022 verfügte die Gruppe über 16 Produktionsstandorte weltweit.
Mitarbeiterzahl: 8 887
Umsatz nach Geschäftsbereich
| ZAR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Regional Brands
46,2
%
| 17 405 | 45,1 % | 18 824 | 46,2 % | +8,15 % |
Manufacturing
27,8
%
| 10 948 | 28,4 % | 11 297 | 27,8 % | +3,19 % |
Sterile Focus Brands
26,0
%
| 10 253 | 26,6 % | 10 588 | 26,0 % | +3,27 % |
Umsatz je Region
| ZAR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Europe & Commonwealth of Independent States
36,0
%
| 13 105 | 33,9 % | 14 637 | 36,0 % | +11,69 % |
Africa and Middle East
21,6
%
| 10 275 | 26,6 % | 8 800 | 21,6 % | -14,36 % |
Australasia
16,1
%
| 5 703 | 14,8 % | 6 554 | 16,1 % | +14,92 % |
Asia
13,8
%
| 5 228 | 13,5 % | 5 620 | 13,8 % | +7,50 % |
Americas
12,5
%
| 4 295 | 11,1 % | 5 098 | 12,5 % | +18,70 % |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Stephen Saad
FOU | Founder | 60 | - |
Sean Capazorio
DFI | Director of Finance/CFO | 57 | 01.01.99 |
| Chief Operating Officer | 60 | 01.01.99 | |
Reginald Haman
BRD | Director/Board Member | 50 | 01.03.23 |
Zizipho Mmango
PRN | Corporate Officer/Principal | 39 | 01.05.20 |
Trevor Ziman
PRN | Corporate Officer/Principal | 49 | 01.05.01 |
| Corporate Officer/Principal | - | - |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
| Director/Board Member | 63 | 01.01.99 | |
Stephen Saad
FOU | Founder | 60 | - |
Kuseni Dlamini
CHM | Chairman | 53 | 01.04.12 |
Barend Kruger
BRD | Director/Board Member | 65 | 01.04.19 |
Yvonne Muthien
BRD | Director/Board Member | 67 | 10.12.21 |
Themba Mkhwanazi
BRD | Director/Board Member | 54 | 01.04.19 |
Linda de Beer
BRD | Director/Board Member | 55 | 31.07.18 |
David Redfern
BRD | Director/Board Member | 57 | 01.02.15 |
Sean Capazorio
DFI | Director of Finance/CFO | 57 | 01.01.99 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 446 252 332 | 267 981 958 ( 60,05 %) | 2 014 078 ( 0,4513 %) | 60,05 % |
Unternehmenskontakt
Aspen Pharmacare Holdings Ltd.
Aspen Place, 9 Rydall Vale Park Douglas Saunders Drive
4019, Durban
+27 31 580 8600
http://www.aspenpharma.com
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Aspen Sp zoo
 Aspen Sp zoo Aspen Sp zoo provides cleaning and maintenance services. Its offer includes cleaning of commercial properties, disinfection, disinfestation, repairs as well as internal and external maintenance. The company was founded in 1996 and is headquartered in Krakow, Poland. | |
Aspen Global, Inc.
 Aspen Global, Inc. Pharmaceuticals: MajorHealth Technology Part of Aspen Pharmacare Holdings Ltd., Aspen Global, Inc. is a Mauritian multinational pharmaceutical company with a 170-year heritage. The private company has a presence in both emerging and developed markets and is based in Grand Baie, Mauritius. Aspen's revenue is predominantly from regional brands in the commercial pharmaceuticals segment, with Mexico and Brazil being the largest regional performers. Aspen has 23 manufacturing facilities across 15 sites and approximately 9,100 employees. The company recently donated life-saving surgical anaesthetics to Lebanese patients and is committed to improving the health of patients through excellence, integrity, innovation, commitment, and teamwork. |
Pharmaceuticals: Major
|
Aspen Oss BV
 Aspen Oss BV Pharmaceuticals: MajorHealth Technology Part of Aspen Pharmacare Holdings Ltd., Aspen Oss BV is a pharmaceutical company that manufactures and supplies pharmaceutical products. The private company is based in Oss, Netherlands. The Dutch company was founded in 1923. The CEO is Stephen Bradley Saad. |
Pharmaceuticals: Major
|
Aspen Pharma Ireland Ltd.
 Aspen Pharma Ireland Ltd. Medical DistributorsDistribution Services Part of Aspen Pharmacare Holdings Ltd., Aspen Pharma Ireland Ltd. is an Irish company that wholesales pharmaceutical goods. The private company is based in Dublin, Ireland. Aspen Pharma Ireland was founded in 2013. |
Medical Distributors
|
Pharmacare Ltd. (South Africa)
 Pharmacare Ltd. (South Africa) Pharmaceuticals: MajorHealth Technology Pharmacare Ltd. manufactures and supplies pharmaceutical products. The company is headquartered in Johannesburg South Africa. |
Pharmaceuticals: Major
|
Aspen Finance (Pty) Ltd.
 Aspen Finance (Pty) Ltd. Financial ConglomeratesFinance Aspen Finance (Pty) Ltd. provides financial assistance services. The company is headquartered in Johannesburg, South Africa. |
Financial Conglomerates
|
Aspen Healthcare FZ LLC
 Aspen Healthcare FZ LLC Medical DistributorsDistribution Services Part of Aspen Pharmacare Holdings Ltd., Aspen Healthcare FZ LLC is an Emirati multinational pharmaceutical company with a 170-year heritage. The private company is based in Dubai, United Arab Emirates. The company has a presence in both emerging and developed markets, with approximately 9,100 employees and 23 manufacturing facilities on 15 sites across 6 continents. Aspen Healthcare FZ improves the health of patients through excellence, integrity, innovation, commitment, and teamwork. |
Medical Distributors
|
Aspen Mexico S de RL de CV
 Aspen Mexico S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Aspen Pharmacare Holdings Ltd., Aspen Mexico S de RL de CV is a Mexican company that manufactures and distributes pharmaceutical products. The private company is based in Azcapotzalco, Mexico. |
Pharmaceuticals: Major
|
Aspen Pharmacare Canada, Inc.
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| +7,71 % | 5,09 Mrd. | |
| +20,91 % | 43,54 Mrd. | |
| +16,96 % | 21,74 Mrd. | |
| +7,98 % | 13,02 Mrd. | |
| +6,84 % | 13,53 Mrd. | |
| +33,80 % | 11,28 Mrd. | |
| -11,05 % | 6,99 Mrd. | |
| -0,05 % | 6,79 Mrd. | |
| -8,87 % | 5,73 Mrd. | |
| +3,49 % | 4,42 Mrd. |
